AMRYT PHARMA PLC - SPNR ADR (AMYT) Stock Income Statement
NASDAQ:AMYT - Nasdaq - US03217L1061 - ADR - Currency: USD
| TTM (2021-9-30) | 2020 (2020-12-31) | 2019 (2019-12-31) | 2018 (2018-12-31) | 2017 (2017-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 210.24M | 182.61M | 58.12M | 17.09M | 14.97M | |||
| Cost Of Goods | 106.81M | 119.03M | 38.73M | 6.27M | 6.30M | |||
| Gross Profit | 103.42M | 63.58M | 19.39M | 10.83M | 8.68M | |||
| Operating Expenses | 126.77M | 109.02M | 52.17M | 28.87M | 25.32M | |||
| Research and Development | 33.59M | 27.62M | 15.83M | 10.70M | 12.38M | |||
| Selling, General, and Administrative Expenses | 93.18M | 81.40M | 36.34M | 18.16M | 12.95M | |||
| Operating Income | -23.35M | -45.44M | -32.77M | -18.04M | -16.65M | |||
| Interest Income/Expense | -24.24M | -19.57M | -4.76M | -1.82M | -951.50K | |||
| Other Income/Expense | -41.59M | -39.83M | -8.25M | -10.59M | -13.03M | |||
| Non Recurring Items | -11.24M | -1.02M | -17.71M | 0.00 | 0.00 | |||
| Income Before Taxes | -100.42M | -105.86M | -63.49M | -30.44M | -30.63M | |||
| Income Tax | -12.89M | -1.33M | -495.00K | 43.00K | 0.00 | |||
| Net Income | -87.53M | -104.53M | -63.00M | -30.49M | -30.63M | |||
| EBITDA | 23.04M | -977.00K | -20.12M | -17.67M | -16.34M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -0.48 | -0.66 | -0.83 | -0.67 | -0.82 | |||
| Statistics | ||||||||
| Gross Profit Margin | 49.19% | 34.82% | 33.36% | 63.35% | 57.95% | |||
| Profit Margin | -41.64% | -57.24% | -108.39% | -178.34% | -204.54% | |||
| Operating Profit Margin | -11.11% | -24.89% | -56.39% | -105.51% | -111.18% | |||
All data in USD